申请人:The Upjohn Company
公开号:US04025629A1
公开(公告)日:1977-05-24
Novel p-(trifluoromethylquinolylamino)benzamides are provided, for example, p-[(7-trifluoromethyl-4-quinolyl)-amino]-N,N-(3-methyl-3-azapentamethylene )benzamide and 1-[p-[[7-(trifluoromethyl)-4-quinolyl]amino]benzoyl]piperazine dihydrochloride. Also provided are pharmaceutical dosage unit forms for systemic administration and methods for their systemic administration. The compound, dosage unit forms and methods of systemic administration are useful in obtaining antihypertensive and anti-anxiety effects in mammals.
提供了新型p-(三氟甲基喹啉基氨基)苯甲酰胺,例如p-[(7-三氟甲基-4-喹啉基)-氨基]-N,N-(3-甲基-3-氮杂戊亚甲基)苯甲酰胺和1-[p-[[7-(三氟甲基)-4-喹啉基]氨基]苯甲酰]哌嗪二盐酸盐。还提供了用于全身给药的药物剂量单位形式和全身给药方法。这种化合物、剂量单位形式和全身给药方法对于获得哺乳动物的降压和抗焦虑效果是有用的。